Results of the Combined U.S. Multicenter Pivotal Study and the Continuing Access Study of the Nit-Occlud PDA Device for Percutaneous Closure of Patent Ductus Arteriosus
Keywords: coil; occluder device; patent ductus arteriosus; AE; adverse event(s); FDA; U.S. Food and Drug Administration; OPC; objective performance criteria; PDA; patent ductus arteriosus (arteriosi);